Sagiment Biosciences Stock Quote SGMT - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

4.34

Bid

4.32

Ask

4.34

Volume

88,665

4.1626 Day's Range 4.40

2.13 52 Week Range 20.71

Market Cap

92.555M

Previous Close

4.28

Open

4.27

Last Trade

4.33

Last Trade Time

10:26:44

Financial Volume

$ 379,258

VWAP

4.2774

Average Volume (3m)

811,211

Shares Outstanding

21,375,402

Dividend Yield

PE Ratio

-3.32

Earnings Per Share (EPS)

-1.3

Revenue

Net Profit

-27.88M

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment ... Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Camden, Delaware, USA

Founded

1970

Sagiment Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SGMT. The last closing price for Sagiment Biosciences was $4.28. Over the last year, Sagiment Biosciences shares have traded in a share price range of $ 2.13 to $ 20.71.

Sagiment Biosciences currently has 21,375,402 shares outstanding. The market capitalization of Sagiment Biosciences is $92.56 million. Sagiment Biosciences has a price to earnings ratio (PE ratio) of -3.32.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.12	2.84360189573	4.22	4.95	3.9	672987	4.26275424	CS
4	-1.08	-19.926199262	5.42	5.53	3.83	448032	4.38111941	CS
12	-3.2	-42.4403183024	7.54	8.75	3.83	811211	5.45754656	CS
26	0.59	15.7333333333	3.75	20.71	2.13	1006869	10.26854447	CS
52	-11.16	-72	15.5	20.71	2.13	663899	10.35216851	CS
156	-11.16	-72	15.5	20.71	2.13	663899	10.35216851	CS
260	-11.16	-72	15.5	20.71	2.13	663899	10.35216851	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GSUNGolden Sun Health Technology Group Ltd	$ 6.0102 (107.25%)	24.3M
NUWENewellis Inc	$ 0.2689 (57.25%)	93.19M
MTCMMTec Inc	$ 3.1299 (36.08%)	25.61M
FGENFibroGen Inc	$ 1.5005 (29.35%)	10.99M
MSGMMotorsport Games Inc	$ 2.84 (25.11%)	2.68M
NUVOHoldco Nuvo Group DG Ltd	$ 3.4801 (-33.71%)	833.12k
AGRIAgriFORCE Growing Systems Ltd	$ 0.101 (-30.06%)	2.35M
RGFReal Good Food Company Inc	$ 0.5675 (-28.06%)	623.91k
STIMNeuronetics Inc	$ 2.7725 (-26.07%)	254.52k
OCGOriental Culture Holdings Ltd	$ 1.15 (-25.43%)	1.14k
FFIEFaraday Future Intelligent Electric Inc	$ 0.0432 (4.60%)	108.79M
NUWENewellis Inc	$ 0.2689 (57.25%)	93.19M
NKLANikola Corporation	$ 0.6018 (-5.59%)	68M
CMNDClearmind Medicine Inc	$ 1.38 (17.95%)	44.57M
RIVNRivian Automotive Inc	$ 10.4399 (1.06%)	30.99M